Khandwa Bio-Tech Private Limited
About Khandwa Bio-Tech Private Limited
Data last updated:
Khandwa Bio-Tech Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the power transmission and distribution services segment of the energy and power sector. It was incorporated on 07 August 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24124MP2008PTC021017.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sanjiv Bansal and Parkash Chand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 Princess Business Sky Park, Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.86 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹9.29 Cr (net margin 17.6%) and EBITDA of ₹29.57 Cr (EBITDA margin 55.9%). Revenue has grown at a compounded annual rate (CAGR) of 865% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Khandwa Bio-Tech Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressB – 1 (B) Part – 3 Princess Business Sky Park, A.B. Road, Indore, Madhya Pradesh, India – 452010
- IndustryEnergy and Power, Power Transmission & Distribution Services
To see the full contact details of Khandwa Bio-Tech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Khandwa Bio-Tech Private Limited
FY 2025 filings availableKhandwa Bio-Tech Private Limited reported revenue of ₹52.86 Cr (up 577% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 865% over three years, including 577% growth in the latest year. EBITDA rose 341% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.57 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.29 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 55.9% | ||||
| Net Profit Margin | 17.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Khandwa Bio-Tech Private Limited, buy the company report.
Board of directors of Khandwa Bio-Tech Private Limited
Khandwa Bio-Tech has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjiv Bansal Also directs: Sankha Diagnostics LLP, Morgan Ventures Limited, Namedi Foods Private Limited and 3 more | Director | 18 Nov 2023 | 2 Years 11 Months | Current |
| Parkash Chand Also directs: Praveen Securities and Investments Private Limited | Director | 18 Nov 2023 | 2 Years 11 Months | Current |
| Mahendra Singh Bora | Director | 18 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Khandwa Bio-Tech Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biofusion Therapeutics Limited | ₹56.53 Cr (FY 2023) | 41.0% | Bengaluru, Karnataka, India | |||
| Yapan Bio Private Limited | ₹55.8 Cr (FY 2025) | 87.0% | Shameerpet, Telangana, India | |||
| 3B Blackbio Biotech India Limited | ₹55.39 Cr (FY 2023) | -25.0% | Bhopal, Madhya Pradesh, India | |||
| Emesar Vaigyanik Annusandhan Kendra (A Private Company) | ₹54.38 Cr (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Actimus Biosciences Private Limited | ₹53.57 Cr (FY 2025) | 10.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Khandwa Bio-Tech Private Limitedthis company | ₹52.86 Cr (FY 2025) | ₹9.29 Cr | 17.6% | 577.0% | Indore, Madhya Pradesh, India | |
| Chemtek Scientific Private Limited | ₹52.2 Cr (FY 2025) | 10.0% | Thane, Maharashtra, India | |||
| SSK Biosciences Private Limited | ₹49.41 Cr (FY 2025) | 2.0% | Hyderabad, Telangana, India | |||
| Navkisan Bio Plaantec Limited | ₹47.15 Cr (FY 2024) | 56.0% | Hyderabad, Telangana, India | |||
| Saveer Biotech Limited | ₹46.01 Cr (FY 2025) | -6.0% | New Delhi, Delhi, India | |||
| Avience Biomedicals Limited | ₹45.91 Cr (FY 2025) | 88.0% | New Delhi, Delhi, India |
To see the full peer comparison of Khandwa Bio-Tech Private Limited, buy the company report.
Auditor
Khandwa Bio-Tech Private Limited is audited by DSP & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DSP & ASSOCIATES | FY 2023 | 006791N |
Shareholding
The shareholding of Khandwa Bio-Tech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Khandwa Bio-Tech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Khandwa Bio-Tech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Khandwa Bio-Tech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Khandwa Bio-Tech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Khandwa Bio-Tech Private Limited has 11 board changes on record since 2009: 3 appointments and 8 cessations. The latest: Mahendra Singh Bora ceased to be Additional Director on 29 Sep 2024.
2 earlier events are in the company report.
Frequently asked questions
Khandwa Bio-Tech is an active private limited company based in Indore, Madhya Pradesh, India. The company works in power transmission and distribution services, within the energy and power industry. It was incorporated on 07 August 2008 (18+ years old) and is registered under CIN U24124MP2008PTC021017.
Khandwa Bio-Tech has 3 current directors:
- Sanjiv Bansal - Director
- Parkash Chand - Director
- Mahendra Singh Bora - Director
The latest financial statements of Khandwa Bio-Tech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Khandwa Bio-Tech is U24124MP2008PTC021017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Khandwa Bio-Tech was incorporated on 07 August 2008, making it 18+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Khandwa Bio-Tech by revenue are Biofusion Therapeutics Limited, Yapan Bio Private Limited, 3B Blackbio Biotech India Limited, Emesar Vaigyanik Annusandhan Kendra (A Private Company), Actimus Biosciences Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Mahendra Singh Bora ceased to be Additional Director on 29 Sep 2024. Parkash Chand ceased to be Additional Director on 29 Sep 2024. Sanjiv Bansal ceased to be Additional Director on 29 Sep 2024. Khandwa Bio-Tech has 11 board changes on record in total.
The registered office of Khandwa Bio-Tech is at B – 1 B Part – 3 Princess Business Sky Park, A.B. Road, Indore, Madhya Pradesh, India – 452010.
Khandwa Bio-Tech operates in the energy and power industry, in the power transmission and distribution services segment.
The compliance status of Khandwa Bio-Tech is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.
Khandwa Bio-Tech can be reached at its registered office: B – 1 B Part – 3 Princess Business Sky Park, A.B. Road, Indore, Madhya Pradesh, India – 452010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
